MRK Stock: Merck & Co., Inc. Stock Price, Analysis & Insights
Get live mrk stock price $86.28, comprehensive Merck & Co., Inc. stock analysis, charts, news, and expert forecast. Real-time mrk stock data and investment insights.
Loading chart...
Company Overview
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Company Information
- CEO
- Robert M. Davis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 73000
Contact Information
- Website
- https://www.merck.com
- Address
- 2000 Galloping Hill Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 215.5 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 11.4)
✓ Lower volatility stock (Beta: 0.32) may provide portfolio stability
Business Model & Strategy
Merck & Co., Inc. operates in the Drug Manufacturers - General industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a large-cap company, Merck & Co., Inc. benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Robert M. Davis, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - General model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Merck & Co., Inc. competes in the Drug Manufacturers - General within the broader Healthcare. With 215.5 billion in market capitalization, the company is positioned as a market leader in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Merck & Co., Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Merck & Co., Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Merck & Co., Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Merck & Co., Inc.
- ⚠Investors should consider how Merck & Co., Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
215.50B
P/E Ratio
11.41
Beta
0.32
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 215.50B market capitalization
- Trading Volume: 7.16M shares traded today
- Price Range: 52-week range of $73.31 - $105.07
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Merck & Co., Inc.
Merck & Co., Inc. (MRK) operates in the Drug Manufacturers - General industry within the Healthcare sector. With a current market capitalization of 215.50B, the company represents a significant player in its market. The stock is currently trading at $86.28 with a positivedaily change of 0.58%.
The company's 73000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 11.41, beta of 0.32, and 52-week price range from $73.31 to $105.07when evaluating investment opportunities.
Why Invest in Merck & Co., Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Robert M. Davis
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.